Abstract:Background: The colonization of Staphylococcus aureus (SA) acquired in nosocomial infections may develop acute and chronic infections such as Methicillin-Resistant Staphylococcus aureus (MRSA) in the nose. As a commensal microorganism with the ability to form a biofilm, SA can dwell on the skin, nostrils, throat, perineum, and axillae of healthy humans. Nitric oxide (NO) is an unstable gas with various molecular functions and has antimicrobial properties which are converted into many potential treatments. Methods: Methicillin-Resistant Staphylococcus aureus MRSA BAA1686 isolated from nasal infection was used in a porcine wound infection model. Deep partial-thickness wounds (10mm x 7mm x 0.5mm) were made on three animals using a specialized electrokeratome. All wounds were inoculated and then covered with polyurethane film dressings for biofilm formation. After 48 hours, three wounds were recovered from each animal for baseline enumeration. The remaining wounds were randomly assigned to six treatment groups and treated once daily. The treatment groups are as follows: NO topical ointments concentrations of 0.3, 0.9 and 1.8%, Vehicle Ointment, Mupirocin 2%, and Untreated Control. Microbiological recoveries were conducted on day 4 and day 7. Results: The greatest efficacy observed from the NO formulations against MRSA BAA1686 was the 1.8% concentration. This agent was able to reduce more than 99% of bacterial counts when compared to Baseline, Vehicle Ointment, and Untreated Control wounds on both assessment days. Mupirocin 2% was the overall best treatment against MRSA BAA1686 on both assessment days, with a significant reduction (p ≤ 0.05) of 4.70 ± 0.13 Log CFU/mL from day 4 to day 7. Conclusions: Overall, the positive control Mupirocin 2% was the most effective in eliminating MRSA BAA1686 throughout the study. This experiment demonstrated a downward trend from the highest concentration of NO topical ointment formulations to the lowest concentrations on both assessment days (0.3% - 1.8%). Out of all NO topical ointments, the highest concentration (1.8%) was the most effective with the potential to be an alternative treatment against a MRSA nasal strain biofilm.

Nitric Oxide Releasing Two-Part Creams Containing S-nitrosoglutathione and Zinc Oxide for Potential Topical Antimicrobial Applications

Nitric Oxide as an Efficient Antimicrobial Treatment for Second-Degree Burn Wounds

Analysis of the broad‐spectrum potential of nitric oxide for antibacterial activity against clinically isolated drug‐resistant bacteria

A Self-Activated NO-releasing Hydrogel Depot for Photothermal Enhanced Sterilization

The efficacy of a nitric oxide-releasing formulation on nares isolated Methicillin-Resistant Staphylococcus aureus in porcine wound infection model

Nitric oxide-releasing self-healing hydrogel for antibacterial and antibiofilm efficacy against polymicrobial infection

Flexible Electrostatic Hydrogels from Marine Organism for Nitric Oxide-Enhanced Photodynamic Therapy Against Multidrug-Resistant Bacterial Infection

Roles and current applications of S-nitrosoglutathione in anti-infective biomaterials

Nitric Oxide-Releasing Polymeric Materials for Antimicrobial Applications: A Review

Photoactivated Release of Nitric Oxide and Antimicrobial Peptide Derivatives for Synergistic Therapy of Bacterial Skin Abscesses

High-Density Three-Dimensional Network of Covalently Linked Nitric Oxide Donors to Achieve Antibacterial and Antibiofilm Surfaces.

Design and Application of an in Situ Traceable Nitric Oxide Donor for Promoting the Healing of Wound Infections

A Multifunctional Nanozyme with NADH Dehydrogenase-Like Activity and Nitric Oxide Release under Near-Infrared Light Irradiation as an Efficient Therapeutic for Antimicrobial Resistance Infection and Wound Healing

Chitosan-graft-PAMAM Loading Nitric Oxide for Efficient Antibacterial Application

Near-infrared-guided NO generator for combined NO/photothermal/chemodynamic therapy of bacterial infections

Functionalized Zinc Oxide Microparticles for Improving the Antimicrobial Effects of Skin-Care Products and Wound-Care Medicines.

Antibacterial Activity of Zinc Oxide Nanoparticles Loaded with Essential Oils

Topical Nano Clove/Thyme Gel against Genetically Identified Clinical Skin Isolates: In Vivo Targeting Behavioral Alteration and IGF-1/pFOXO-1/PPAR γ Cues

Photoresponsive Vesicles Enabling Sequential Release of Nitric Oxide (NO) and Gentamicin for Efficient Biofilm Eradication

Design and Application of an in Situ Traceable NO Donor for Promoting the Healing of Wound Infections

Sustained Endogenous Nitric Oxide Catalytic System Endows Skin Scaffolds with Antibiofilm and Antibacterial Activities